{"id":"placebo-20-intralipid","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site reaction"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"featherless-qwen","explanation":"Intralipid is a fat emulsion used as a vehicle for parenteral nutrition. In clinical trials, it can serve as a placebo to control for the physical effects of receiving an intravenous solution.","oneSentence":"Placebo (20% Intralipid) does not have an active pharmacological effect; it serves as a control in clinical trials.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:26:24.670Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT07362446","phase":"PHASE2","title":"Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction","status":"NOT_YET_RECRUITING","sponsor":"Nyrada Pty Ltd","startDate":"2026-04-16","conditions":"Myocardial Infarction, Reperfusion Injury, AMI","enrollment":300},{"nctId":"NCT06890039","phase":"PHASE2","title":"A-TANGO Phase 2 Study","status":"NOT_YET_RECRUITING","sponsor":"Yaqrit Ltd","startDate":"2025-09-01","conditions":"Acute-On-Chronic Liver Failure, Alcoholic Hepatitis, Liver Cirrhosis, Alcoholic","enrollment":78},{"nctId":"NCT04832009","phase":"EARLY_PHASE1","title":"Reversing Glucose and Lipid-mediated Vascular Dysfunction","status":"RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2022-05-09","conditions":"Blood Pressure, Hypertension","enrollment":46},{"nctId":"NCT05139563","phase":"NA","title":"South African Male User Research on Acceptability of Implants and Injections","status":"COMPLETED","sponsor":"RTI International","startDate":"2022-07-12","conditions":"Acceptability","enrollment":184},{"nctId":"NCT04328337","phase":"PHASE1, PHASE2","title":"Investigating Whether Acute Elevation of Fatty Acid Levels Alters Cerebral Glucose Transport and Metabolism","status":"RECRUITING","sponsor":"University of North Carolina, Chapel Hill","startDate":"2020-12-08","conditions":"Obesity","enrollment":40},{"nctId":"NCT04558190","phase":"NA","title":"Mitochondrial Dysfunction and Insulin Resistance in Skeletal Muscle","status":"COMPLETED","sponsor":"University of Copenhagen","startDate":"2020-09-02","conditions":"Insulin Resistance","enrollment":10},{"nctId":"NCT04806425","phase":"PHASE4","title":"The Cardioprotective Effect of Intralipid in Decreasing the Ischemic Insults During Off-pump Coronary Artery Revascularization","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2020-10-01","conditions":"Anesthesia","enrollment":46},{"nctId":"NCT01679561","phase":"PHASE4","title":"Intralipid Therapy for Recurrent Implantation Failure and Recurrent Miscarriages: Is it a Hope or Myth?A Randomized Clinical Trial","status":"WITHDRAWN","sponsor":"Woman's Health University Hospital, Egypt","startDate":"2012-02","conditions":"Pregnancy Complicated by Low Implantation","enrollment":""},{"nctId":"NCT04592380","phase":"PHASE3","title":"Clevidipine vs Placebo or Standard of Care for Dyspnea and Blood Pressure Control in AHF","status":"WITHDRAWN","sponsor":"The Medicines Company","startDate":"2014-08","conditions":"Dyspnea, Hypertension, Acute Heart Failure","enrollment":""},{"nctId":"NCT02365285","phase":"PHASE1, PHASE2","title":"Racial Differences in Vagal Control of Glucose Homeostasis","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2015-03","conditions":"Obesity","enrollment":23},{"nctId":"NCT02406586","phase":"NA","title":"Free Fatty Acids-Induced Hypertension in Obese Subjects (Aim #2)","status":"COMPLETED","sponsor":"Emory University","startDate":"2009-07","conditions":"Hypertension, Diabetes","enrollment":36},{"nctId":"NCT02691533","phase":"NA","title":"To Study the Immunomodulating Effects and Safety Profile of ω3 and ω6 PUFA Containing Intravenous Lipid Emulsion in Patients With Acute on Chronic Liver Failure","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2016-02-01","conditions":"Chronic Liver Failure","enrollment":90},{"nctId":"NCT01520454","phase":"NA","title":"Effect of Increased Free Fatty Acids on Leptin Function","status":"COMPLETED","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2011-11","conditions":"Obesity, Leptin Resistance","enrollment":26},{"nctId":"NCT02771912","phase":"PHASE4","title":"Patient-controlled Sedation With Propofol During Cataract Surgery Under Topical Anesthesia","status":"COMPLETED","sponsor":"Fondation Ophtalmologique Adolphe de Rothschild","startDate":"2016-07","conditions":"Sedation","enrollment":60},{"nctId":"NCT02487940","phase":"PHASE4","title":"Assessment of Intralipid Efficacy in Women With Unexplained Recurrent Implantation Failure","status":"COMPLETED","sponsor":"Dar El Teb Institute","startDate":"2012-10","conditions":"Subfertility","enrollment":100},{"nctId":"NCT02865785","phase":"PHASE1, PHASE2","title":"Effect of Intralipid Infusion in Patients With Recurrent Implantation Failure","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2016-07","conditions":"Subfertility","enrollment":320},{"nctId":"NCT01529515","phase":"PHASE3","title":"A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2012-05","conditions":"Schizophrenia","enrollment":509},{"nctId":"NCT01515423","phase":"PHASE3","title":"Study of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Patients With Schizophrenia","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2012-05","conditions":"Schizophrenia","enrollment":1429},{"nctId":"NCT00822900","phase":"PHASE3","title":"Progesterone for the Treatment of Traumatic Brain Injury III","status":"TERMINATED","sponsor":"David Wright","startDate":"2010-03","conditions":"Traumatic Brain Injury","enrollment":882},{"nctId":"NCT02462772","phase":"PHASE2","title":"Safety and Acceptability of Cabotegravir in HIV Uninfected Women in KwaZulu-Natal, South Africa","status":"WITHDRAWN","sponsor":"Centre for the AIDS Programme of Research in South Africa","startDate":"2015-10","conditions":"Human Immunodeficiency Virus","enrollment":""},{"nctId":"NCT00111189","phase":"PHASE3","title":"A Study of the Efficacy (Effectiveness) of Paliperidone Palmitate in the Prevention of Recurrence of the Symptoms of Schizophrenia.","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2005-02","conditions":"Schizophrenia","enrollment":414}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":30,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo (20% Intralipid)","genericName":"Placebo (20% Intralipid)","companyName":"Janssen Research & Development, LLC","companyId":"johnson-johnson","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":false,"safety":true,"trials":true,"score":3}}